OBJECTIVES: To determine the value of adding a third reader for arbitration of discrepant screening mammography assessments. METHODS: We included a consecutive series of 84,927 digital screening mammograms, double read in a blinded or non-blinded fashion. Arbitration was retrospectively performed by a third screening radiologist. Two years' follow-up was performed. RESULTS: Discrepant readings comprised 57.2% (830/1452) and 29.1% (346/1188) of recalls at blinded and non-blinded double readings, respectively. At blinded double reading, arbitration would have decreased recall rate (3.4 to 2.2%, p < 0.001) and programme sensitivity (83.2 to 76.0%, p = 0.013), would not have influenced the cancer detection rate (CDR; 7.5 to 6.8 per 1,000 screens, p = 0.258) and would have increased the positive predictive value of recall (PPV; 22.3 to 31.2%, p < 0.001). At non-blinded double reading, arbitration would have decreased recall rate (2.8 to 2.3%, p < 0.001) and increased PPV (23.2 to 27.5%, p = 0.021), but would not have affected CDR (6.6 to 6.3 per 1,000 screens, p = 0.604) and programme sensitivity (76.0 to 72.7%, p = 0.308). CONCLUSION: Arbitration of discrepant screening mammography assessments is a good tool to improve recall rate and PPV, but is not desirable as it reduces the programme sensitivity at blinded double reading. KEY POINTS: • Blinded double reading results in higher programme sensitivity than non-blinded reading. • Discrepant readings occur more often at blinded compared to non-blinded reading. • Arbitration of discrepant readings reduces the recall rate and PPV. • Arbitration would reduce the programme sensitivity at blinded double reading.
OBJECTIVES: To determine the value of adding a third reader for arbitration of discrepant screening mammography assessments. METHODS: We included a consecutive series of 84,927 digital screening mammograms, double read in a blinded or non-blinded fashion. Arbitration was retrospectively performed by a third screening radiologist. Two years' follow-up was performed. RESULTS: Discrepant readings comprised 57.2% (830/1452) and 29.1% (346/1188) of recalls at blinded and non-blinded double readings, respectively. At blinded double reading, arbitration would have decreased recall rate (3.4 to 2.2%, p < 0.001) and programme sensitivity (83.2 to 76.0%, p = 0.013), would not have influenced the cancer detection rate (CDR; 7.5 to 6.8 per 1,000 screens, p = 0.258) and would have increased the positive predictive value of recall (PPV; 22.3 to 31.2%, p < 0.001). At non-blinded double reading, arbitration would have decreased recall rate (2.8 to 2.3%, p < 0.001) and increased PPV (23.2 to 27.5%, p = 0.021), but would not have affected CDR (6.6 to 6.3 per 1,000 screens, p = 0.604) and programme sensitivity (76.0 to 72.7%, p = 0.308). CONCLUSION: Arbitration of discrepant screening mammography assessments is a good tool to improve recall rate and PPV, but is not desirable as it reduces the programme sensitivity at blinded double reading. KEY POINTS: • Blinded double reading results in higher programme sensitivity than non-blinded reading. • Discrepant readings occur more often at blinded compared to non-blinded reading. • Arbitration of discrepant readings reduces the recall rate and PPV. • Arbitration would reduce the programme sensitivity at blinded double reading.
Authors: R Román; M Sala; M De La Vega; C Natal; J Galceran; I González-Román; A Baroja; R Zubizarreta; N Ascunce; D Salas; X Castells Journal: Breast Cancer Res Treat Date: 2011-05-27 Impact factor: 4.872
Authors: T Leivo; T Salminen; H Sintonen; R Tuominen; K Auerma; K Partanen; U Saari; M Hakama; O P Heinonen Journal: Breast Cancer Res Treat Date: 1999-04 Impact factor: 4.872
Authors: Johannes D M Otten; Nico Karssemeijer; Jan H C L Hendriks; Johanna H Groenewoud; Jacques Fracheboud; André L M Verbeek; Harry J de Koning; Roland Holland Journal: J Natl Cancer Inst Date: 2005-05-18 Impact factor: 13.506
Authors: Angela M P Coolen; Joost R C Lameijer; Adri C Voogd; Marieke W J Louwman; Luc J Strobbe; Vivianne C G Tjan-Heijnen; Lucien E M Duijm Journal: Eur Radiol Date: 2018-06-25 Impact factor: 5.315
Authors: Jennifer A Cooper; David Jenkinson; Chris Stinton; Matthew G Wallis; Sue Hudson; Sian Taylor-Phillips Journal: Eur Radiol Date: 2021-06-12 Impact factor: 5.315